In conversation

New mechanical thrombectomy systems unlock possibilities for the treatment of venous...

Anthony Strzalek - 1st November 2022 0

Why ClotTriever is a “gamechanger” for the treatment of deep vein...

Anthony Strzalek - 6th September 2022 0

CLEAR-DVT highlights “real paradigm shift” in treatment of DVT patients

Anthony Strzalek - 6th August 2020 0

Manj Gohel Dan Carradice and Alun Davies 766x512

Early intervention for leg ulcers a global “golden opportunity” to improve...

liamdonovan - 10th February 2020 0

Deep venous interventions are an exciting area, but “stark evidence gaps”...

BIBA Publishing - 13th December 2018 0

US FDA clears ThinkSono’s ultrasound AI software for deep vein thrombosis

29th July 2026

Greater anxiety-depressive symptoms associated with poorer pain response following venous intervention...

13th August 2026

UK Biobank study identifies absence of genetic risk for chronic venous...

13th July 2026

Features

Q&A: Research needed to tackle post-hospital discharge DVT care “deficit”

12th May 2026

Q&A: US FDA clearance next step for pain-lessening varicose vein surgery...

8th May 2026

Venous News’ top stories of 2025

2nd January 2026

Profiles

Kathleen Ozsvath

13th March 2025

Kush Desai

24th October 2024

Gloria Salazar

10th June 2024

The burgeoning PE care landscape, part two: “Moving the needle to help thousands of patients”

The burgeoning PE care landscape, part one: “From no data to a lot...

Pathways and multidisciplinary teams “critical” in shaping future venous care

STEVECO trial catalyzes need for “a new era” of post-thrombotic syndrome patient management

Venous valve technologies set to address “large unmet need worldwide”